Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by WatchLearnEarnon Apr 25, 2017 1:57pm

115 Views

Post# 26163726

RE:RE:RE:RE:RE:RE:Lots of volume at 0.15-0.16 lately

Correction: My buy filled at .115 (damn rounding quotes) so I don't feel AS bad...

WatchLearnEarn wrote: The US ticker (ATBPF) is in freefall apparently. I had a buy get filled yesterday at .12 after opening at .13 and it's down again today to .105, but I'm out of cash. Dangit.

StrikingMoose wrote:
I have learned that most morningstar estimates are poppycock lol.

That being said, I do believe ATE is worth vastly more than 15 cents.

Even taking the pipeline out and focussing on citagenix they are making more revenue than other pennies who are worth more.

Maybe the presentation at the Bloom investor conference will spark some interest. Maybe not. I wish we had some toxicology information on ATB350 though, that is going to be exciting to see as well. I think from september this year to april/may next year this stock is going to be going through some pretty awesome changes.